1 Study Coverage 1.1 Cefpodoxime Proxetil Tablets Product Introduction 1.2 Market by Type 1.2.1 Global Cefpodoxime Proxetil Tablets Market Size Growth Rate by Type 1.2.2 100mg 1.2.3 200mg 1.2.4 Other 1.3 Market by Application 1.3.1 Global Cefpodoxime Proxetil Tablets Market Size Growth Rate by Application 1.3.2 Respiratory Tract Infection 1.3.3 Skin and Soft Tissue Infections 1.3.4 Urinary Tract Infection 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Cefpodoxime Proxetil Tablets Market Size, Estimates and Forecasts 2.1.1 Global Cefpodoxime Proxetil Tablets Revenue 2016-2027 2.1.2 Global Cefpodoxime Proxetil Tablets Sales 2016-2027 2.2 Global Cefpodoxime Proxetil Tablets, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Cefpodoxime Proxetil Tablets Historical Market Size by Region (2016-2021) 2.3.1 Global Cefpodoxime Proxetil Tablets Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Cefpodoxime Proxetil Tablets Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Cefpodoxime Proxetil Tablets Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Cefpodoxime Proxetil Tablets Sales Forecast by Region (2022-2027) 2.4.2 Global Cefpodoxime Proxetil Tablets Revenue Forecast by Region (2022-2027) 3 Global Cefpodoxime Proxetil Tablets Competitor Landscape by Players 3.1 Global Top Cefpodoxime Proxetil Tablets Manufacturers by Sales 3.1.1 Global Cefpodoxime Proxetil Tablets Sales by Manufacturer (2016-2021) 3.1.2 Global Cefpodoxime Proxetil Tablets Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Cefpodoxime Proxetil Tablets Manufacturers by Revenue 3.2.1 Key Cefpodoxime Proxetil Tablets Manufacturers Covered: Ranking by Revenue 3.2.2 Global Cefpodoxime Proxetil Tablets Revenue by Manufacturers (2016-2021) 3.2.3 Global Cefpodoxime Proxetil Tablets Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Cefpodoxime Proxetil Tablets Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Cefpodoxime Proxetil Tablets Revenue in 2020 3.2.6 Global Cefpodoxime Proxetil Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Cefpodoxime Proxetil Tablets Price by Manufacturers 3.4 Global Cefpodoxime Proxetil Tablets Manufacturing Base Distribution, Product Types 3.4.1 Cefpodoxime Proxetil Tablets Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Cefpodoxime Proxetil Tablets Product Type 3.4.3 Date of International Manufacturers Enter into Cefpodoxime Proxetil Tablets Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Cefpodoxime Proxetil Tablets Market Size by Type (2016-2021) 4.1.1 Global Cefpodoxime Proxetil Tablets Sales by Type (2016-2021) 4.1.2 Global Cefpodoxime Proxetil Tablets Revenue by Type (2016-2021) 4.1.3 Cefpodoxime Proxetil Tablets Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Cefpodoxime Proxetil Tablets Market Size Forecast by Type (2022-2027) 4.2.1 Global Cefpodoxime Proxetil Tablets Sales Forecast by Type (2022-2027) 4.2.2 Global Cefpodoxime Proxetil Tablets Revenue Forecast by Type (2022-2027) 4.2.3 Cefpodoxime Proxetil Tablets Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Cefpodoxime Proxetil Tablets Market Size by Application (2016-2021) 5.1.1 Global Cefpodoxime Proxetil Tablets Sales by Application (2016-2021) 5.1.2 Global Cefpodoxime Proxetil Tablets Revenue by Application (2016-2021) 5.1.3 Cefpodoxime Proxetil Tablets Price by Application (2016-2021) 5.2 Cefpodoxime Proxetil Tablets Market Size Forecast by Application (2022-2027) 5.2.1 Global Cefpodoxime Proxetil Tablets Sales Forecast by Application (2022-2027) 5.2.2 Global Cefpodoxime Proxetil Tablets Revenue Forecast by Application (2022-2027) 5.2.3 Global Cefpodoxime Proxetil Tablets Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Cefpodoxime Proxetil Tablets Market Size YoY Growth 2016-2027 6.1.1 China Cefpodoxime Proxetil Tablets Sales YoY Growth 2016-2027 6.1.2 China Cefpodoxime Proxetil Tablets Revenue YoY Growth 2016-2027 6.1.3 China Cefpodoxime Proxetil Tablets Market Share in Global Market 2016-2027 6.2 China Cefpodoxime Proxetil Tablets Market Size by Players (International and Local Players) 6.2.1 China Top Cefpodoxime Proxetil Tablets Players by Sales (2016-2021) 6.2.2 China Top Cefpodoxime Proxetil Tablets Players by Revenue (2016-2021) 6.3 China Cefpodoxime Proxetil Tablets Historic Market Review by Type (2016-2021) 6.3.1 China Cefpodoxime Proxetil Tablets Sales Market Share by Type (2016-2021) 6.3.2 China Cefpodoxime Proxetil Tablets Revenue Market Share by Type (2016-2021) 6.3.3 China Cefpodoxime Proxetil Tablets Price by Type (2016-2021) 6.4 China Cefpodoxime Proxetil Tablets Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Cefpodoxime Proxetil Tablets Sales Forecast by Type (2022-2027) 6.4.2 China Cefpodoxime Proxetil Tablets Revenue Forecast by Type (2022-2027) 6.4.3 China Cefpodoxime Proxetil Tablets Price Forecast by Type (2022-2027) 6.5 China Cefpodoxime Proxetil Tablets Historic Market Review by Application (2016-2021) 6.5.1 China Cefpodoxime Proxetil Tablets Sales Market Share by Application (2016-2021) 6.5.2 China Cefpodoxime Proxetil Tablets Revenue Market Share by Application (2016-2021) 6.5.3 China Cefpodoxime Proxetil Tablets Price by Application (2016-2021) 6.6 China Cefpodoxime Proxetil Tablets Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Cefpodoxime Proxetil Tablets Sales Forecast by Application (2022-2027) 6.6.2 China Cefpodoxime Proxetil Tablets Revenue Forecast by Application (2022-2027) 6.6.3 China Cefpodoxime Proxetil Tablets Price Forecast by Application (2022-2027) 7 North America 7.1 North America Cefpodoxime Proxetil Tablets Market Size YoY Growth 2016-2027 7.2 North America Cefpodoxime Proxetil Tablets Market Facts & Figures by Country 7.2.1 North America Cefpodoxime Proxetil Tablets Sales by Country (2016-2021) 7.2.2 North America Cefpodoxime Proxetil Tablets Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Cefpodoxime Proxetil Tablets Market Size YoY Growth 2016-2027 8.2 Asia Pacific Cefpodoxime Proxetil Tablets Market Facts & Figures by Region 8.2.1 Asia Pacific Cefpodoxime Proxetil Tablets Sales by Region (2016-2021) 8.2.2 Asia Pacific Cefpodoxime Proxetil Tablets Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Cefpodoxime Proxetil Tablets Market Size YoY Growth 2016-2027 9.2 Europe Cefpodoxime Proxetil Tablets Market Facts & Figures by Country 9.2.1 Europe Cefpodoxime Proxetil Tablets Sales by Country (2016-2021) 9.2.2 Europe Cefpodoxime Proxetil Tablets Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Cefpodoxime Proxetil Tablets Market Size YoY Growth 2016-2027 10.2 Latin America Cefpodoxime Proxetil Tablets Market Facts & Figures by Country 10.2.1 Latin America Cefpodoxime Proxetil Tablets Sales by Country (2016-2021) 10.2.2 Latin America Cefpodoxime Proxetil Tablets Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Cefpodoxime Proxetil Tablets Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Cefpodoxime Proxetil Tablets Market Facts & Figures by Country 11.2.1 Middle East and Africa Cefpodoxime Proxetil Tablets Sales by Country (2016-2021) 11.2.2 Middle East and Africa Cefpodoxime Proxetil Tablets Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Pfizer 12.1.1 Pfizer Corporation Information 12.1.2 Pfizer Description and Business Overview 12.1.3 Pfizer Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Pfizer Cefpodoxime Proxetil Tablets Products Offered 12.1.5 Pfizer Recent Development 12.2 Novartis 12.2.1 Novartis Corporation Information 12.2.2 Novartis Description and Business Overview 12.2.3 Novartis Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Novartis Cefpodoxime Proxetil Tablets Products Offered 12.2.5 Novartis Recent Development 12.3 Sun Pharma 12.3.1 Sun Pharma Corporation Information 12.3.2 Sun Pharma Description and Business Overview 12.3.3 Sun Pharma Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Sun Pharma Cefpodoxime Proxetil Tablets Products Offered 12.3.5 Sun Pharma Recent Development 12.4 Cadila Healthcare 12.4.1 Cadila Healthcare Corporation Information 12.4.2 Cadila Healthcare Description and Business Overview 12.4.3 Cadila Healthcare Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Cadila Healthcare Cefpodoxime Proxetil Tablets Products Offered 12.4.5 Cadila Healthcare Recent Development 12.5 Lupin 12.5.1 Lupin Corporation Information 12.5.2 Lupin Description and Business Overview 12.5.3 Lupin Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Lupin Cefpodoxime Proxetil Tablets Products Offered 12.5.5 Lupin Recent Development 12.6 Aurobindo Pharma 12.6.1 Aurobindo Pharma Corporation Information 12.6.2 Aurobindo Pharma Description and Business Overview 12.6.3 Aurobindo Pharma Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Aurobindo Pharma Cefpodoxime Proxetil Tablets Products Offered 12.6.5 Aurobindo Pharma Recent Development 12.7 Torrent Pharma 12.7.1 Torrent Pharma Corporation Information 12.7.2 Torrent Pharma Description and Business Overview 12.7.3 Torrent Pharma Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Torrent Pharma Cefpodoxime Proxetil Tablets Products Offered 12.7.5 Torrent Pharma Recent Development 12.8 Innova Captab 12.8.1 Innova Captab Corporation Information 12.8.2 Innova Captab Description and Business Overview 12.8.3 Innova Captab Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Innova Captab Cefpodoxime Proxetil Tablets Products Offered 12.8.5 Innova Captab Recent Development 12.9 Wellona Pharma 12.9.1 Wellona Pharma Corporation Information 12.9.2 Wellona Pharma Description and Business Overview 12.9.3 Wellona Pharma Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Wellona Pharma Cefpodoxime Proxetil Tablets Products Offered 12.9.5 Wellona Pharma Recent Development 12.10 SwisscheM Healthcare 12.10.1 SwisscheM Healthcare Corporation Information 12.10.2 SwisscheM Healthcare Description and Business Overview 12.10.3 SwisscheM Healthcare Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.10.4 SwisscheM Healthcare Cefpodoxime Proxetil Tablets Products Offered 12.10.5 SwisscheM Healthcare Recent Development 12.11 Pfizer 12.11.1 Pfizer Corporation Information 12.11.2 Pfizer Description and Business Overview 12.11.3 Pfizer Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Pfizer Cefpodoxime Proxetil Tablets Products Offered 12.11.5 Pfizer Recent Development 12.12 Skymax Life Science 12.12.1 Skymax Life Science Corporation Information 12.12.2 Skymax Life Science Description and Business Overview 12.12.3 Skymax Life Science Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Skymax Life Science Products Offered 12.12.5 Skymax Life Science Recent Development 12.13 Zhejiang Jingxin Pharmaceutical 12.13.1 Zhejiang Jingxin Pharmaceutical Corporation Information 12.13.2 Zhejiang Jingxin Pharmaceutical Description and Business Overview 12.13.3 Zhejiang Jingxin Pharmaceutical Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Zhejiang Jingxin Pharmaceutical Products Offered 12.13.5 Zhejiang Jingxin Pharmaceutical Recent Development 12.14 Hainan Hailing Chemipharma Corporation 12.14.1 Hainan Hailing Chemipharma Corporation Corporation Information 12.14.2 Hainan Hailing Chemipharma Corporation Description and Business Overview 12.14.3 Hainan Hailing Chemipharma Corporation Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Hainan Hailing Chemipharma Corporation Products Offered 12.14.5 Hainan Hailing Chemipharma Corporation Recent Development 12.15 Zhejiang Kangle Pharmaceutical 12.15.1 Zhejiang Kangle Pharmaceutical Corporation Information 12.15.2 Zhejiang Kangle Pharmaceutical Description and Business Overview 12.15.3 Zhejiang Kangle Pharmaceutical Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Zhejiang Kangle Pharmaceutical Products Offered 12.15.5 Zhejiang Kangle Pharmaceutical Recent Development 12.16 Dawnrays Pharma 12.16.1 Dawnrays Pharma Corporation Information 12.16.2 Dawnrays Pharma Description and Business Overview 12.16.3 Dawnrays Pharma Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Dawnrays Pharma Products Offered 12.16.5 Dawnrays Pharma Recent Development 12.17 Sichuan Hexin 12.17.1 Sichuan Hexin Corporation Information 12.17.2 Sichuan Hexin Description and Business Overview 12.17.3 Sichuan Hexin Cefpodoxime Proxetil Tablets Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Sichuan Hexin Products Offered 12.17.5 Sichuan Hexin Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Cefpodoxime Proxetil Tablets Industry Trends 13.2 Cefpodoxime Proxetil Tablets Market Drivers 13.3 Cefpodoxime Proxetil Tablets Market Challenges 13.4 Cefpodoxime Proxetil Tablets Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Cefpodoxime Proxetil Tablets Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Cefpodoxime Proxetil Tablets Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of 100mg Table 3. Major Manufacturers of 200mg Table 4. Major Manufacturers of Other Table 5. Global Cefpodoxime Proxetil Tablets Market Size Growth Rate by Application (2021-2027) & (K Units) Table 6. Global Cefpodoxime Proxetil Tablets Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Cefpodoxime Proxetil Tablets Sales by Regions (2016-2021) & (K Units) Table 8. Global Cefpodoxime Proxetil Tablets Sales Market Share by Regions (2016-2021) Table 9. Global Cefpodoxime Proxetil Tablets Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Cefpodoxime Proxetil Tablets Sales Forecast by Region (2022-2027) & (K Units) Table 11. Global Cefpodoxime Proxetil Tablets Sales Market Share Forecast by Region (2022-2027) Table 12. Global Cefpodoxime Proxetil Tablets Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Cefpodoxime Proxetil Tablets Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Cefpodoxime Proxetil Tablets Sales by Manufacturers (2016-2021) (K Units) Table 15. Global Cefpodoxime Proxetil Tablets Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Cefpodoxime Proxetil Tablets Manufacturers by Revenue (US$ Million) in 2020 Table 17. Cefpodoxime Proxetil Tablets Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Cefpodoxime Proxetil Tablets Revenue Share by Manufacturers (2016-2021) Table 19. Global Cefpodoxime Proxetil Tablets Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Cefpodoxime Proxetil Tablets by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cefpodoxime Proxetil Tablets as of 2020) Table 21. Key Manufacturers Cefpodoxime Proxetil Tablets Price (2016-2021) (US$/Unit) Table 22. Cefpodoxime Proxetil Tablets Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Cefpodoxime Proxetil Tablets Product Type Table 24. Date of International Manufacturers Enter into Cefpodoxime Proxetil Tablets Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Cefpodoxime Proxetil Tablets Sales by Type (2016-2021) (K Units) Table 27. Global Cefpodoxime Proxetil Tablets Sales Share by Type (2016-2021) Table 28. Global Cefpodoxime Proxetil Tablets Revenue by Type (2016-2021) (US$ Million) Table 29. Global Cefpodoxime Proxetil Tablets Revenue Share by Type (2016-2021) Table 30. Cefpodoxime Proxetil Tablets Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 31. Global Cefpodoxime Proxetil Tablets Sales Forecast by Type (2022-2027) & (K Units) Table 32. Global Cefpodoxime Proxetil Tablets Sales Market Share Forecast by Type (2022-2027) Table 33. Global Cefpodoxime Proxetil Tablets Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Cefpodoxime Proxetil Tablets Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Cefpodoxime Proxetil Tablets Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 36. Global Cefpodoxime Proxetil Tablets Sales by Application (2016-2021) (K Units) Table 37. Global Cefpodoxime Proxetil Tablets Sales Share by Application (2016-2021) Table 38. Global Cefpodoxime Proxetil Tablets Revenue by Application (2016-2021) (US$ Million) Table 39. Global Cefpodoxime Proxetil Tablets Revenue Share by Application (2016-2021) Table 40. Cefpodoxime Proxetil Tablets Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 41. Global Cefpodoxime Proxetil Tablets Sales Forecast by Application (2022-2027) & (K Units) Table 42. Global Cefpodoxime Proxetil Tablets Sales Market Share Forecast by Application (2022-2027) Table 43. Global Cefpodoxime Proxetil Tablets Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Cefpodoxime Proxetil Tablets Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Cefpodoxime Proxetil Tablets Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 46. China Cefpodoxime Proxetil Tablets Sales (K Units) of Key Companies (2016-2021) Table 47. China Cefpodoxime Proxetil Tablets Sales Share by Company (2016-2021) Table 48. China Cefpodoxime Proxetil Tablets Revenue (US$ Million) by Company (2016-2021) Table 49. China Cefpodoxime Proxetil Tablets Revenue Share by Company (2016-2021) Table 50. China Cefpodoxime Proxetil Tablets Sales (K Units) by Type (2016-2021) Table 51. China Cefpodoxime Proxetil Tablets Sales Share by Type (2016-2021) Table 52. China Cefpodoxime Proxetil Tablets Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. China Cefpodoxime Proxetil Tablets Price (US$/Unit) by Type (2016-2021) Table 54. China Cefpodoxime Proxetil Tablets Sales (K Units) by Type (2022-2027) Table 55. China Cefpodoxime Proxetil Tablets Sales Share by Type (2022-2027) Table 56. China Cefpodoxime Proxetil Tablets Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. China Cefpodoxime Proxetil Tablets Revenue Share by Type (2022-2027) Table 58. China Cefpodoxime Proxetil Tablets Price (US$/Unit) by Type (2022-2027) Table 59. China Cefpodoxime Proxetil Tablets Sales (K Units) by Application (2016-2021) Table 60. China Cefpodoxime Proxetil Tablets Sales Share by Application (2016-2021) Table 61. China Cefpodoxime Proxetil Tablets Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. China Cefpodoxime Proxetil Tablets Price (US$/Unit) by Application (2016-2021) Table 63. China Cefpodoxime Proxetil Tablets Sales (K Units) by Application (2022-2027) Table 64. China Cefpodoxime Proxetil Tablets Sales Share by Application (2022-2027) Table 65. China Cefpodoxime Proxetil Tablets Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. China Cefpodoxime Proxetil Tablets Revenue Share by Application (2022-2027) Table 67. China Cefpodoxime Proxetil Tablets Price (US$/Unit) by Application (2022-2027) Table 68. North America Cefpodoxime Proxetil Tablets Sales by Country (2016-2021) & (K Units) Table 69. North America Cefpodoxime Proxetil Tablets Sales Market Share by Country (2016-2021) Table 70. North America Cefpodoxime Proxetil Tablets Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Cefpodoxime Proxetil Tablets Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Cefpodoxime Proxetil Tablets Sales by Region (2016-2021) & (K Units) Table 73. Asia Pacific Cefpodoxime Proxetil Tablets Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Cefpodoxime Proxetil Tablets Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Cefpodoxime Proxetil Tablets Revenue Market Share by Region (2016-2021) Table 76. Europe Cefpodoxime Proxetil Tablets Sales by Country (2016-2021) & (K Units) Table 77. Europe Cefpodoxime Proxetil Tablets Sales Market Share by Country (2016-2021) Table 78. Europe Cefpodoxime Proxetil Tablets Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Cefpodoxime Proxetil Tablets Revenue Market Share by Country (2016-2021) Table 80. Latin America Cefpodoxime Proxetil Tablets Sales by Country (2016-2021) & (K Units) Table 81. Latin America Cefpodoxime Proxetil Tablets Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Cefpodoxime Proxetil Tablets Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Cefpodoxime Proxetil Tablets Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Cefpodoxime Proxetil Tablets Sales by Country (2016-2021) & (K Units) Table 85. Middle East and Africa Cefpodoxime Proxetil Tablets Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Cefpodoxime Proxetil Tablets Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Cefpodoxime Proxetil Tablets Revenue Market Share by Country (2016-2021) Table 88. Pfizer Corporation Information Table 89. Pfizer Description and Business Overview Table 90. Pfizer Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. Pfizer Cefpodoxime Proxetil Tablets Product Table 92. Pfizer Recent Development Table 93. Novartis Corporation Information Table 94. Novartis Description and Business Overview Table 95. Novartis Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. Novartis Product Table 97. Novartis Recent Development Table 98. Sun Pharma Corporation Information Table 99. Sun Pharma Description and Business Overview Table 100. Sun Pharma Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. Sun Pharma Product Table 102. Sun Pharma Recent Development Table 103. Cadila Healthcare Corporation Information Table 104. Cadila Healthcare Description and Business Overview Table 105. Cadila Healthcare Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. Cadila Healthcare Product Table 107. Cadila Healthcare Recent Development Table 108. Lupin Corporation Information Table 109. Lupin Description and Business Overview Table 110. Lupin Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 111. Lupin Product Table 112. Lupin Recent Development Table 113. Aurobindo Pharma Corporation Information Table 114. Aurobindo Pharma Description and Business Overview Table 115. Aurobindo Pharma Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 116. Aurobindo Pharma Product Table 117. Aurobindo Pharma Recent Development Table 118. Torrent Pharma Corporation Information Table 119. Torrent Pharma Description and Business Overview Table 120. Torrent Pharma Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 121. Torrent Pharma Product Table 122. Torrent Pharma Recent Development Table 123. Innova Captab Corporation Information Table 124. Innova Captab Description and Business Overview Table 125. Innova Captab Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 126. Innova Captab Product Table 127. Innova Captab Recent Development Table 128. Wellona Pharma Corporation Information Table 129. Wellona Pharma Description and Business Overview Table 130. Wellona Pharma Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 131. Wellona Pharma Product Table 132. Wellona Pharma Recent Development Table 133. SwisscheM Healthcare Corporation Information Table 134. SwisscheM Healthcare Description and Business Overview Table 135. SwisscheM Healthcare Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 136. SwisscheM Healthcare Product Table 137. SwisscheM Healthcare Recent Development Table 138. West Coast Pharmaceuticals Corporation Information Table 139. West Coast Pharmaceuticals Description and Business Overview Table 140. West Coast Pharmaceuticals Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 141. West Coast Pharmaceuticals Product Table 142. West Coast Pharmaceuticals Recent Development Table 143. Skymax Life Science Corporation Information Table 144. Skymax Life Science Description and Business Overview Table 145. Skymax Life Science Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 146. Skymax Life Science Product Table 147. Skymax Life Science Recent Development Table 148. Zhejiang Jingxin Pharmaceutical Corporation Information Table 149. Zhejiang Jingxin Pharmaceutical Description and Business Overview Table 150. Zhejiang Jingxin Pharmaceutical Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 151. Zhejiang Jingxin Pharmaceutical Product Table 152. Zhejiang Jingxin Pharmaceutical Recent Development Table 153. Hainan Hailing Chemipharma Corporation Corporation Information Table 154. Hainan Hailing Chemipharma Corporation Description and Business Overview Table 155. Hainan Hailing Chemipharma Corporation Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 156. Hainan Hailing Chemipharma Corporation Product Table 157. Hainan Hailing Chemipharma Corporation Recent Development Table 158. Zhejiang Kangle Pharmaceutical Corporation Information Table 159. Zhejiang Kangle Pharmaceutical Description and Business Overview Table 160. Zhejiang Kangle Pharmaceutical Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 161. Zhejiang Kangle Pharmaceutical Product Table 162. Zhejiang Kangle Pharmaceutical Recent Development Table 163. Dawnrays Pharma Corporation Information Table 164. Dawnrays Pharma Description and Business Overview Table 165. Dawnrays Pharma Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 166. Dawnrays Pharma Product Table 167. Dawnrays Pharma Recent Development Table 168. Sichuan Hexin Corporation Information Table 169. Sichuan Hexin Description and Business Overview Table 170. Sichuan Hexin Cefpodoxime Proxetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 171. Sichuan Hexin Product Table 172. Sichuan Hexin Recent Development Table 173. Cefpodoxime Proxetil Tablets Market Trends Table 174. Cefpodoxime Proxetil Tablets Market Drivers Table 175. Cefpodoxime Proxetil Tablets Market Challenges Table 176. Cefpodoxime Proxetil Tablets Market Restraints Table 177. Cefpodoxime Proxetil Tablets Customers List Table 178. Cefpodoxime Proxetil Tablets Distributors List Table 179. Research Programs/Design for This Report Table 180. Key Data Information from Secondary Sources Table 181. Key Data Information from Primary Sources List of Figures Figure 1. Cefpodoxime Proxetil Tablets Product Picture Figure 2. Global Cefpodoxime Proxetil Tablets Sales Market Share by Type in 2020 & 2027 Figure 3. 100mg Product Picture Figure 4. 200mg Product Picture Figure 5. Other Product Picture Figure 6. Global Cefpodoxime Proxetil Tablets Sales Market Share by Application in 2020 & 2027 Figure 7. Respiratory Tract Infection Figure 8. Skin and Soft Tissue Infections Figure 9. Urinary Tract Infection Figure 10. Other Figure 11. Cefpodoxime Proxetil Tablets Report Years Considered Figure 12. Global Cefpodoxime Proxetil Tablets Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Cefpodoxime Proxetil Tablets Market Size 2016-2027 (US$ Million) Figure 14. Global Cefpodoxime Proxetil Tablets Sales 2016-2027 (K Units) Figure 15. Global Cefpodoxime Proxetil Tablets Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global Cefpodoxime Proxetil Tablets Sales Market Share by Region (2016-2021) Figure 17. Global Cefpodoxime Proxetil Tablets Sales Market Share by Region in 2020 Figure 18. Global Cefpodoxime Proxetil Tablets Revenue Market Share by Region (2016-2021) Figure 19. Global Cefpodoxime Proxetil Tablets Revenue Market Share by Region in 2020 Figure 20. Global Cefpodoxime Proxetil Tablets Sales Share by Manufacturer in 2020 Figure 21. The Top 10 and 5 Players Market Share by Cefpodoxime Proxetil Tablets Revenue in 2020 Figure 22. Cefpodoxime Proxetil Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Cefpodoxime Proxetil Tablets Sales Market Share by Type (2016-2021) Figure 24. Global Cefpodoxime Proxetil Tablets Sales Market Share by Type in 2020 Figure 25. Global Cefpodoxime Proxetil Tablets Revenue Market Share by Type (2016-2021) Figure 26. Global Cefpodoxime Proxetil Tablets Revenue Market Share by Type in 2020 Figure 27. Global Cefpodoxime Proxetil Tablets Sales Market Share by Application (2016-2021) Figure 28. Global Cefpodoxime Proxetil Tablets Sales Market Share by Application in 2020 Figure 29. Global Cefpodoxime Proxetil Tablets Revenue Market Share by Application (2016-2021) Figure 30. Global Cefpodoxime Proxetil Tablets Revenue Market Share by Application in 2020 Figure 31. China Cefpodoxime Proxetil Tablets Sales Growth Rate 2016-2027 (K Units) Figure 32. China Cefpodoxime Proxetil Tablets Revenue Growth Rate 2016-2027 (US$ Million) Figure 33. China Cefpodoxime Proxetil Tablets Market Share in Global Market 2016-2027 Figure 34. China 5 and 10 Largest Cefpodoxime Proxetil Tablets Players Market Share by Revenue in Cefpodoxime Proxetil Tablets in 2020 Figure 35. China Cefpodoxime Proxetil Tablets Revenue Share by Type (2016-2021) Figure 36. China Cefpodoxime Proxetil Tablets Revenue Growth Rate by Type in 2016 & 2020 Figure 37. China Cefpodoxime Proxetil Tablets Revenue Share by Application (2016-2021) Figure 38. China Cefpodoxime Proxetil Tablets Revenue Growth Rate by Application in 2016 & 2020 Figure 39. North America Cefpodoxime Proxetil Tablets Sales Growth Rate 2016-2021 (K Units) Figure 40. North America Cefpodoxime Proxetil Tablets Revenue Growth Rate 2016-2021 (US$ Million) Figure 41. North America Cefpodoxime Proxetil Tablets Sales Market Share by Country in 2020 Figure 42. North America Cefpodoxime Proxetil Tablets Revenue Market Share by Country in 2020 Figure 43. U.S. Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 44. U.S. Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Canada Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 46. Canada Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Europe Cefpodoxime Proxetil Tablets Sales Growth Rate 2016-2021 (K Units) Figure 48. Europe Cefpodoxime Proxetil Tablets Revenue Growth Rate 2016-2021 (US$ Million) Figure 49. Europe Cefpodoxime Proxetil Tablets Sales Market Share by Country in 2020 Figure 50. Europe Cefpodoxime Proxetil Tablets Revenue Market Share by Country in 2020 Figure 51. Germany Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 52. Germany Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. France Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 54. France Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. U.K. Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 56. U.K. Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Italy Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 58. Italy Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Russia Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 60. Russia Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Asia Pacific Cefpodoxime Proxetil Tablets Sales Growth Rate 2016-2021 (K Units) Figure 62. Asia Pacific Cefpodoxime Proxetil Tablets Revenue Growth Rate 2016-2021 (US$ Million) Figure 63. Asia Pacific Cefpodoxime Proxetil Tablets Sales Market Share by Region in 2020 Figure 64. Asia Pacific Cefpodoxime Proxetil Tablets Revenue Market Share by Region in 2020 Figure 65. China Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 66. China Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Japan Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 68. Japan Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. South Korea Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 70. South Korea Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. India Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 72. India Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Australia Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 74. Australia Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Taiwan Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 76. Taiwan Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Indonesia Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 78. Indonesia Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Thailand Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 80. Thailand Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Malaysia Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 82. Malaysia Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Philippines Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 84. Philippines Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Vietnam Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 86. Vietnam Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Latin America Cefpodoxime Proxetil Tablets Sales Growth Rate 2016-2021 (K Units) Figure 88. Latin America Cefpodoxime Proxetil Tablets Revenue Growth Rate 2016-2021 (US$ Million) Figure 89. Latin America Cefpodoxime Proxetil Tablets Sales Market Share by Country in 2020 Figure 90. Latin America Cefpodoxime Proxetil Tablets Revenue Market Share by Country in 2020 Figure 91. Mexico Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 92. Mexico Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Brazil Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 94. Brazil Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Argentina Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 96. Argentina Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Middle East and Africa Cefpodoxime Proxetil Tablets Sales Growth Rate 2016-2021 (K Units) Figure 98. Middle East and Africa Cefpodoxime Proxetil Tablets Revenue Growth Rate 2016-2021 (US$ Million) Figure 99. Middle East and Africa Cefpodoxime Proxetil Tablets Sales Market Share by Country in 2020 Figure 100. Middle East and Africa Cefpodoxime Proxetil Tablets Revenue Market Share by Country in 2020 Figure 101. Turkey Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 102. Turkey Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Saudi Arabia Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 104. Saudi Arabia Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. UAE Cefpodoxime Proxetil Tablets Sales Growth Rate (2016-2021) (K Units) Figure 106. UAE Cefpodoxime Proxetil Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. Cefpodoxime Proxetil Tablets Value Chain Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

Pfizer Novartis Sun Pharma Cadila Healthcare Lupin Aurobindo Pharma Torrent Pharma Innova Captab Wellona Pharma SwisscheM Healthcare West Coast Pharmaceuticals Skymax Life Science Zhejiang Jingxin Pharmaceutical Hainan Hailing Chemipharma Corporation Zhejiang Kangle Pharmaceutical Dawnrays Pharma Sichuan Hexin